A Survey of Knowledge and Practices in Generic Prescribing Among Doctors in Kurunegala District, Sri Lanka

Abstract

Generic prescribing is promoted by most governments and insurers as a measure of reducing health care cost. Doctors are key players health care provision and powerful deciders in drug market. The practice of doctors in prescribing is critical in determining both clinical and economic efficiency and effectiveness of a health system. The study was questionnaire based and conducted in Kurunegala district in Sri Lanka with the participation of government doctors. It was revealed that most doctors were engaged in generic prescribing and they had a satisfactory knowledge regarding the concept. Practice of generic prescribing among doctors was not significantly associated with their work experience, gender, engagement in private practice or post graduate qualifications. It was depicted that the promotional visits by representatives of pharmaceutical companies mainly focused at doctors who did part time private practice. Yet it was claimed that most doctors did not consider brand name when purchasing drugs for their practices.

Keywords

• Generic Prescribing
• Knowledge
• Practices
• Doctors
• Sri Lanka

References

1. Banahan, B. F. (1997). A Physician Survey on Generic Drugs and Substitution of Critical Dose Medications. Archives of Internal Medicine, 157(18), 2080. https://doi.org/10.1001/archinte.1997.00440390066010
2. Carthy, P., Harvey, I., Brawn, R., & Watkins, C. (2000). A study of factors associated with cost and variation in prescribing among GPs. Family Practice, 17(1), 36–41. https://doi.org/10.1093/fampra/17.1.36
3. Davies, K. (2007). The information-seeking behaviour of doctors: A review of the evidence. Health Information and Libraries Journal, 24(2), 78–94. https://doi.org/10.1111/j.1471-1842.2007.00713.x
4. De Silva, D. (2017). How many doctors should we train for Sri Lanka? System dynamics modelling of training needs. Ceylon Medical Journal, 62(4). Donohue, J. M., Cevasco, M., & Rosenthal, M. B. (2007). A Decade of Direct-to-Consumer Advertising of Prescription Drugs. New England Journal of Medicine, 357(7), 673–681. https://doi.org/10.1056/NEJMsa070502
5. Gagne, J. J., Choudhry, N. K., Kesselheim, A. S., Polinski, J. M., Hutchins, D., Matlin, O. S., Brennan, T. A., Avorn, J., & Shrank, W. H. (2014). Comparative Effectiveness of Generic and Brand-Name Statins on Patient Outcomes: A Cohort Study. Annals of Internal Medicine, 161(6), 400. https://doi.org/10.7326/M13-2942
6. Jamshed, S. Q., Ibrahim, M. I. M., Hassali, M. A. A., Masood, I., Low, B. Y., Shafie, A. A., & Babar, Z.-U.-D. (2012). Perception and attitude of general practitioners regarding generic medicines in Karachi, Pakistan: A questionnaire based study. Southern Med Review, 5(1), 22–30.
7. Keenum, A. J., DeVoe, J. E., Chisolm, D. J., & Wallace, L. S. (2012). Generic medications for you, but brand-name medications for me. Research in Social and Administrative Pharmacy, 8(6), 574–578. https://doi.org/10.1016/j.sapharm.2011.12.004
8. Kembhavi, R. S., Shinde, R. R., Hagawane, T., Jadhav, R. A., Khairnar, R. R., & Darade, B. D. (n.d.). Cross Sectional, Observational Study to Assess Prescription Practices of Physicians with Respect to Use of Generic Medicines. International Journal of Pharmaceutical Sciences Review and Research, 25(1), 90–96.

9. McCormack, J., & Chmelicek, J. T. (2014). Generic versus brand name: The other drug war. Canadian Family Physician, 60(10), 911.
10. Menik, H., Isuru, A., & Sewwandi, S. (2011). A survey: Precepts and practices in drug use indicators at government healthcare facilities: A hospital-based prospective analysis. Journal of Pharmacy and Bioallied Sciences, 3(1), 165. https://doi.org/10.4103/0975-7406.76502
11. National Medicines Regulatory Authority Act 2015. (No.5). (2015). Government Publications Bureau.
12. Rosenthal, M. B., Berndt, E. R., Donohue, J. M., Frank, R. G., & Epstein, A. M. (2002). Promotion of Prescription Drugs to Consumers. New England Journal of Medicine, 346(7), 498–505. https://doi.org/10.1056/NEJMsa012075
13. Schumock, G. T., Walton, S. M., Park, H. Y., Nutescu, E. A., Blackburn, J. C., Finley, J. M., & Lewis, R. K. (2004). Factors that Influence Prescribing Decisions. Annals of Pharmacotherapy, 38(4), 557–562. https://doi.org/10.1345/aph.1D390
14. Sharifnia, S. H. A., Mohammadzadeh, M., Arzani, G., Salamzadeh, J., Abolfazli, S. A., Zali, A., & Khoshdel, A. R. (2018). Main Factors Affecting Physicians’ Prescribing Decisions: The Iranian Experience. Iranian Journal of Pharmaceutical Research: IJPR, 17(3), 1105–1115.
15. Theodorou, M., Tsiantou, V., Pavlakis, A., Maniadakis, N., Fragoulakis, V., Pavi, E., & Kyriopoulos, J. (2009). Factors influencing prescribing behaviour of physicians in Greece and Cyprus: Results from a questionnaire based survey. BMC Health Services Research, 9(1), 150. https://doi.org/10.1186/1472-6963-9-150
16. Vancelik, S., Beyhun, N. E., Acemoglu, H., & Calikoglu, O. (2007). Impact of pharmaceutical promotion on prescribing decisions of general practitioners in Eastern Turkey. BMC Public Health, 7(1), 122. https://doi.org/10.1186/1471-2458-7-122
17. Wazana, A. (2000). Physicians and the Pharmaceutical Industry: Is a Gift Ever Just a Gift? JAMA, 283(3), 373. https://doi.org/10.1001/jama.283.3.373
18. WHO definitions of generics. (2012). Generics and Biosimilars Inititative. http://gabionline.net/Generics/General/WHO-definitions-of-generics World Health Organization. (2016). WHO Drug Information-Generic medicines.